<SEC-DOCUMENT>0001193125-19-029543.txt : 20190206
<SEC-HEADER>0001193125-19-029543.hdr.sgml : 20190206
<ACCEPTANCE-DATETIME>20190206161130
ACCESSION NUMBER:		0001193125-19-029543
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20190206
FILED AS OF DATE:		20190206
DATE AS OF CHANGE:		20190206

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Nutrien Ltd.
		CENTRAL INDEX KEY:			0001725964
		STANDARD INDUSTRIAL CLASSIFICATION:	AGRICULTURE CHEMICALS [2870]
		IRS NUMBER:				981400416
		STATE OF INCORPORATION:			Z4
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38336
		FILM NUMBER:		19571682

	BUSINESS ADDRESS:	
		STREET 1:		SUITE 500, 122 - 1ST AVENUE SOUTH
		CITY:			SASKATOON
		STATE:			A9
		ZIP:			S7K 7G3
		BUSINESS PHONE:		(306) 933-8500

	MAIL ADDRESS:	
		STREET 1:		SUITE 500, 122 - 1ST AVENUE SOUTH
		CITY:			SASKATOON
		STATE:			A9
		ZIP:			S7K 7G3
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>d692912d6k.htm
<DESCRIPTION>6-K
<TEXT>
<HTML><HEAD>
<TITLE>6-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>Form <FONT
STYLE="white-space:nowrap">6-K</FONT> </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Report of
Foreign Issuer </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Pursuant to <FONT STYLE="white-space:nowrap">Section&nbsp;13a-16</FONT> or
<FONT STYLE="white-space:nowrap">15d-16</FONT> of the </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Securities Exchange Act of 1934 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>For the month of: February, 2019 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Commission File Number: <FONT STYLE="white-space:nowrap">001-38336</FONT> </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>NUTRIEN LTD. </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Name of
registrant) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="50%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Suite 500, 122 &#150; 1st Avenue</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>South Saskatoon, Saskatchewan</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>S7K 7G3 Canada</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>13131 Lake Fraser Drive S.E.</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Calgary, Alberta</B></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>T2J 7E8
Canada</B></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center"><B>(Address of principal executive offices)</B></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant files or will file annual reports under cover of Form <FONT STYLE="white-space:nowrap">20-F</FONT> or Form <FONT
STYLE="white-space:nowrap">40-F:</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Form
<FONT STYLE="white-space:nowrap">20-F&nbsp;&nbsp;&#9744;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Form</FONT>
<FONT STYLE="white-space:nowrap">40-F&nbsp;&nbsp;&#9746;</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark if the registrant is submitting the Form <FONT
STYLE="white-space:nowrap">6-K</FONT> in paper as permitted by Regulation <FONT STYLE="white-space:nowrap">S-T</FONT> Rule 101(b)(1):&nbsp;&nbsp;&#9744; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark if the registrant is submitting the Form <FONT STYLE="white-space:nowrap">6-K</FONT> in paper as permitted by Regulation <FONT
STYLE="white-space:nowrap">S-T</FONT> Rule 101(b)(7):&nbsp;&nbsp;&#9744; </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SIGNATURES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="45%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="44%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><B>NUTRIEN LTD.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date: February&nbsp;6, 2019</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Robert A. Kirkpatrick</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Robert A. Kirkpatrick</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">VP&nbsp;&amp; Corporate Secretary</TD></TR>
</TABLE>
</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT INDEX </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Exhibit</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Description of Exhibit</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">News Release dated February&nbsp;5, 2019</TD></TR>
</TABLE>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d692912dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="51%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:24pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g692912g80s81.jpg" ALT="LOGO">
</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">NYSE, TSX: NTR</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><B>News Release</B></TD></TR>
</TABLE> <P STYLE="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">February 5, 2019 </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman"><B>Nutrien Announces Agreement to Purchase
Actagro </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Loveland, Colorado </B>- Nutrien Ltd. (Nutrien) announced today that it has entered into a definitive agreement to purchase
100&nbsp;percent of the equity of Actagro, LLC (Actagro), a leading developer, manufacturer and marketer of environmentally sustainable soil and plant health products and technologies. Actagro&#146;s premier commercial portfolio includes
approximately 30 specialty products that have a strong track-record of increasing crop productivity and financial returns for growers. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Actagro&#146;s
products are produced at two US manufacturing facilities located in California and Arkansas, and distributed across global agricultural markets through numerous retailers and distributors, including Nutrien&#146;s Retail business. The acquisition
includes Actagro&#146;s strong research and development team, as well as a near-complete, world-class research and development facility located in California that will support the continued development of soil and plant health technologies. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;The acquisition of Actagro is aligned with Nutrien&#146;s strategy to invest in higher-margin proprietary products that provide strong value for
growers. Actagro has a strong track record of developing and manufacturing high-value crop nutrition products and we see a significant opportunity to expand the business by leveraging the global reach of our Retail network and the expansion of
Actagro&#146;s strong relationships with domestic and international distributors. Nutrien will continue to use its strong balance sheet and cash flow to prudently allocate capital towards growth opportunities that create value for our customers and
our shareholders,&#148; commented Chuck Magro, Nutrien&#146;s President and CEO. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The purchase price is US$340&nbsp;million, including approximately
US$20&nbsp;million in working capital, and is expected to be accretive to earnings in the first year. We expect the business to generate approximately US$55&nbsp;million in run-rate EBITDA two years after close with the realization of synergies and
organic growth opportunities. Closing of the transaction is subject to US regulatory approval and is expected to be completed in the first half of 2019. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Nutrien </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Nutrien is the world&#146;s largest
provider of crop inputs and services, playing a critical role in helping growers increase food production in a sustainable manner. We produce and distribute over 26&nbsp;million tonnes of potash, nitrogen and phosphate products world-wide. With this
capability and our leading agriculture retail network, we are well positioned to supply the needs of our customers. We operate with a long-term view and are committed to working with our stakeholders as we address our economic, environmental and
social priorities. The scale and diversity of our integrated portfolio provides a stable earnings base, multiple avenues for growth and the opportunity to return capital to shareholders. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I><FONT STYLE="white-space:nowrap">Forward-Looking</FONT> Statements </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Certain statements and other information included in this press release constitute &#147;forward-looking information&#148; or &#147;forward-looking
statements&#148; (collectively, &#147;forward-looking statements&#148;) under applicable securities laws (such statements are usually accompanied by words such as &#147;anticipate&#148;, &#147;expect&#148;, &#147;believe&#148;,
</I></P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>
&#147;may&#148;, &#147;will&#148;, &#147;should&#148;, &#147;estimate&#148;, &#147;intend&#148; or other similar words). All statements in this press release, other than those relating to
historical information or current conditions, are forward-looking statements, including, but not limited to: expected benefits of the acquisition, including expected impact on earnings, run-rate EBITDA, synergies, growth opportunities and expansion,
as well as the timing of the foregoing; future allocation of capital; timing for the completion of the acquisition; and the ability to satisfy the conditions to, and complete, the acquisition including obtaining required regulatory approval,.
Forward-looking statements in this press release are based on certain key expectations and assumptions made by Nutrien, some of which are outside of Nutrien&#146;s control. Although Nutrien believes that the expectations and assumptions on which
such forward- looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because Nutrien can give no assurance that they will prove to be correct. Additional assumptions that have been made
include, among other things, assumptions with respect to Nutrien&#146;s ability to successfully integrate and realize the anticipated benefits of the acquisition; that Nutrien will be able to implement its standards, controls, procedures and
policies at the acquired business to realize expected synergies; that future business, regulatory and industry conditions will be within the parameters expected by Nutrien, and assumptions with respect to global economic conditions. </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Forward-looking statements are subject to various risks and uncertainties which could cause actual results and experience to differ materially from the
anticipated results or expectations expressed in this press release, including the ability to obtain, and obtain in a timely manner, the required regulatory approval, the ability to otherwise satisfy the conditions to the acquisition, the failure to
successfully integrate and realize expected synergies associated with the acquisition, general global economic, market and business conditions, and other risk factors detailed from time to time in Nutrien reports filed with Canadian securities
regulators and the Securities and Exchange Commission in the United States, including those disclosed in Nutrien&#146;s business acquisition report dated February 20, 2018. </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Nutrien disclaims any intention or obligation to update or revise any forward-looking statements in this press release as a result of new information or
future events, except as may be required under applicable US federal securities laws or applicable Canadian securities legislation. </I></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>FOR FURTHER
INFORMATION: </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Investor and Media Relations: </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Richard Downey </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Vice President, Investor&nbsp;&amp; Corporate
Relations </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(403) 225-7357 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Investor Relations: </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Jeff Holzman </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Senior Director, Investor Relations </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(306) 933-8545 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Todd Coakwell </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Director, Investor Relations </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(403) 225-7437 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Contact us at: www.nutrien.com </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g692912g80s81.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g692912g80s81.jpg
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M,C(R,C(R,C(R,O_  !$( #0 Q@,!(@ "$0$#$0'_Q  ?   !!0$! 0$! 0
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M7QQU YKZ&^&U[KNG?#B]UGQ1<W;W0,LH6ZR&1$& ,'ID@UV?A/21H7A+2M,
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9BB@ HHHH **** "BBB@ HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
